Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

HIV-1 5’-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance Mutations

medRxiv(2023)10.1101/2023.06.04.23290942Source: DataRank Database

HIV-1 5’-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance Mutations is a research paper published in medRxiv (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (15)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Philip L. Tzou ORCID,Soo‐Yon Rhee ORCID,Malaya K. Sahoo ORCID,Benjamin A. Pinsky ORCID,Miri Krupkin ORCID

Live enrichment

PubMed:37333388 OpenAlex:https://openalex.org/W4379377545

NIAID NIH HHS

Grant: R03 AI147682

NIAID NIH HHS

Grant: R21 AI147632

NIAID NIH HHS

Grant: U54 AI170856

greenLicense: cc-by

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2023/08/29/2023.06.04.23290942.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.06.04.23290942

repositoryhttp://dx.doi.org/10.1101/2023.06.04.23290942

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37333388

Fields of Study

HIV Research and TreatmentHIV/AIDS drug development and treatmentinterferon and immune responses

Keywords

Resistance mutationReverse transcriptaseMutationVirologyBiologyVirusGeneticsGenBankNucleotideHuman immunodeficiency virus (HIV)RNAGene

Sustainable Development Goals

SDG 0: Good health and well-being